71 tracked 13F filers disclose a position in MPLT as of the latest SEC 13F filings, a combined $394.5M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Novo Holdings A/S | $74.9M | 3.7M | —Held | Q1 2026 | |
| 2 | FCPM III SERVICES B.V. | $65.6M | 3.2M | —Held | Q1 2026 | |
| 3 | T. Rowe Price Investment Management, Inc. | Withheld | 2.8M | ▲+0.1% Added · +3K sh | Q1 2026 | |
| 4 | GOLDMAN SACHS GROUP INC | $40.6M | 2.0M | ▲+3.0% Added · +58K sh | Q1 2026 | |
| 5 | BlackRock, Inc. | $27.2M | 1.3M | ▲+22% Added · +244K sh | Q1 2026 | |
| 6 | 5AM Venture Management, LLC | $19.3M | 950K | —Held | Q1 2026 | |
| 7 | Sanofi | $32.7M | 912K | —Held | Q2 2026 | |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | $14.6M | 720K | →First observed position No prior filed position | Q1 2026 | |
| 9 | Velan Capital Investment Management LP | $10.0M | 493K | ▼−5.6% Reduced · −29K sh | Q1 2026 | |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | $9.8M | 481K | ▲+24% Added · +92K sh | Q1 2026 | |
| 11 | Siren, L.L.C. | $9.1M | 450K | —Held | Q1 2026 | |
| 12 | Vestal Point Capital, LP | $8.5M | 420K | ▲+9.1% Added · +35K sh | Q1 2026 | |
| 13 | ADAR1 Capital Management, LLC | $7.6M | 375K | ▲New +375K sh | Q1 2026 | |
| 14 | BAKER BROS. ADVISORS LP | $7.4M | 365K | —Held | Q1 2026 | |
| 15 | STATE STREET CORP | $6.9M | 339K | ▲+48% Added · +110K sh | Q1 2026 | |
| 16 | Freestone Grove Partners LP | $6.4M | 314K | ▲+71% Added · +130K sh | Q1 2026 | |
| 17 | BNP Paribas Asset Management Holding S.A. | $5.4M | 268K | ▲+81% Added · +120K sh | Q1 2026 | |
| 18 | RA CAPITAL MANAGEMENT, L.P. | $5.0M | 248K | ▲New +248K sh | Q1 2026 | |
| 19 | UBS Group AG | $4.8M | 237K | ▲13× Added · +218K sh | Q1 2026 | |
| 20 | FMR LLC | $4.2M | 205K | ▲226× Added · +204K sh | Q1 2026 | |
| 21 | DAFNA Capital Management LLC | $3.5M | 171K | ▲+19% Added · +27K sh | Q1 2026 | |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.3M | 161K | ▲+16% Added · +23K sh | Q1 2026 | |
| 23 | NORTHERN TRUST CORP | $3.0M | 146K | ▲+22% Added · +27K sh | Q1 2026 | |
| 24 | LAZARD ASSET MANAGEMENT LLC | $2.9M | 142K | ▼−32% Reduced · −65K sh | Q1 2026 | |
| 25 | VANGUARD FIDUCIARY TRUST CO | $2.7M | 131K | →First observed position No prior filed position | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 8 funds opened a new position in MPLT and 9 added to an existing one, while 6 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| XENON PHARMACEUTICALS INCXENE | 26 funds | $666.2M |
| CYTOKINETICS INCCYTK | 26 funds | $397.1M |
| PRAXIS PRECISION MEDICINES IPRAX | 25 funds | $2.1B |
| CELLDEX THERAPEUTICS INCCLDX | 25 funds | $195.5M |
| MICROSOFT CORPMSFT | 24 funds | $82.3B |
| REVOLUTION MEDICINES INCRVMD | 24 funds | $2.9B |
| VAXCYTE INCPCVX | 24 funds | $1.8B |
| DYNE THERAPEUTICS INCDYN | 24 funds | $545.8M |
| DENALI THERAPEUTICS INCDNLI | 24 funds | $252.2M |
| NVIDIA CORPNVDA | 23 funds | $124.2B |
| AMAZON.COM INCAMZN | 23 funds | $54.2B |
| BROADCOM INCAVGO | 23 funds | $50.7B |
Ranked by how many of MPLT's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Lillie James Woodruff | Chief Scientific Officer | Sell (S) | 22K | $277K |
| Jul 28, 2026 | Cox Troy | Director | Buy (P) | 16K | $149K |
| Jul 17, 2026 | Kroeger Christopher A. | Chief Executive Officer, Director | Sell (S) | 17K | $636K |
| Jul 17, 2026 | Lillie James Woodruff | Chief Scientific Officer | Sell (S) | 2K | $79K |
| Jul 17, 2026 | Hanson Kristopher | General Counsel | Sell (S) | 1K | $43K |
| Jul 17, 2026 | Foff Erin Pennock | Chief Medical Officer | Sell (S) | 4K | $139K |
| Jul 17, 2026 | GILLIS JONATHAN | CAO and Interim CFO | Sell (S) | 600 | $22K |
| Jul 17, 2026 | GILLIS JONATHAN | CAO and Interim CFO | Sell (S) | 17K | $638K |
| Jul 17, 2026 | GILLIS JONATHAN | CAO and Interim CFO | Sell (S) | 900 | $34K |
| Jul 17, 2026 | Kreitzer Anatol | Chief Discovery Officer | Sell (S) | 3K | $105K |
| Jul 17, 2026 | Kreitzer Anatol | Chief Discovery Officer | Sell (S) | 14K | $533K |
| Jul 17, 2026 | Kreitzer Anatol | Chief Discovery Officer | Sell (S) | 200 | $8K |
Connected entities for MPLT
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/MPLT/capital-change-brief"
Use Arkolith's capital_change_brief for MPLT. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for MPLT. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.